Zinc supplementation in intensive care: Results of a UK survey

Journal of Critical Care

Volumn 27, Issue 1, 2012, Pages 102.e1-102.e6

  Duncan, Andrew ^a   Dean, Pamela ^b   Simm, Malcolm ^b   O'Reilly, Denis StJ ^a   Kinsella, John ^b  

^a Scottish Trace Element and Micronutrient Reference Laboratory   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Critical care medicine; Supplementation; Zinc

Indexed keywords

GLUCONATE ZINC; MULTITRACE; UNCLASSIFIED DRUG; ZINC; ZINC SULFATE;

ARTICLE; DIETARY REFERENCE INTAKE; INTENSIVE CARE; QUESTIONNAIRE; UNITED KINGDOM; ZINC BLOOD LEVEL; ZINC DEFICIENCY;

EID: 84856464236     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2011.07.083     Document Type: Article

References (53)

1. Weissman C. Nutrition in the intensive care unit. Crit Care 1999, 3:R67-R75.
2. Galloway P., McMillan D.C., Sattar N. Effect of the inflammatory response on trace element and vitamin status. Ann Clin Biochem 2000, 37:289-297.
3. Min K.S., Terano Y., Onosaka S., et al. Induction of hepatic metallothionein by nonmetallic compounds associated with acute-phase response in inflammation. Toxicol Appl Pharmacol 1991, 111:152-162.
4. Askari A., Long C.L., Blakemore W.S. Urinary zinc, copper, nitrogen, and potassium losses in response to trauma. J Parenteral Enteral Nutr 1979, 3:151-156.
5. Gray R.D., Duncan A., Noble D., et al. Sputum trace metals are biomarkers of inflammatory and suppurative lung disease. Chest 2010, 137:635-641.
6. Bock F.W.J., Prasad A.S., Kaplan J., et al. Changes in cytokines production and T-cell subpopulation in experimentally induced zinc-deficient humans. Am J Physiol 1997, 272:E1002-E1007.
7. Prasad A.S., Mefiah S., Abdallah J., et al. Serum thymulin in human zinc deficiency. J Clin Invest 1988, 82:1202-1210.
8. Chausmer A.B. Zinc, insulin and diabetes. J Am Coll Nutr 1998, 17:109-115.
9. Salvemini D., Cuzzocrea S. Therapeutic potential of superoxide dismutase mimetics as therapeutic agents in critical care medicine. Crit Care Med 2003, 31:S29-S38.
10. Tenaud I., Sainte-Marie I., Jumbou O., et al. In vitro modulation of keratinocyte wound healing integrins by zinc, copper and manganese. Br J Dermatol 1999, 140:26-34.
11. Ruz M., Cavan K.R., Bettger W.J., et al. Development of a dietary model for the sturdy of mild zinc deficiency in humans and evaluation of some biochemical and functional indices of zinc status. Am J Clin Nutr 1991, 53:1295-1303.
12. Taylor A. Detection and monitoring for disorders of essential trace elements. Ann Clin Biochem 1996, 33:486-510.
13. Oakes E.J.C., Lyon T.D.B., Duncan A., et al. Acute inflammatory response does not affect erythrocyte concentrations of copper, zinc and selenium. Clin Nutr 2008, 27:115-120.
14. Sandstead H.H., Prasad A.S., Schulert A.R., et al. Human zinc deficiency, endocrine manifestations and response to treatment. Am J Clin Nutr 1967, 20:422-442.
15. Halsted J.A., Ronaghy H.A., Abadi P., et al. Zinc deficiency in man. The Shiraz experiment. Am J Med 1972, 53:277-284.
16. Kumar N., Gross J.B., Ahlskog J.E. Copper deficiency myelopathy produces a clinical picture like subacute combined degeneration. Neurology 2004, 63:33-39.
17. Willis M.S., Monaghan S.A., Miller M.L., et al. Zinc-induced copper deficiency: a report of three cases initially recognized on bone marrow examination. Am J Clin Pathol 2005, 123:125-131.
18. Rowin J., Lewis S.L. Copper deficiency myeloneuropathy and pancytopenia secondary to overuse of zinc supplementation. J Neurol Neurosurg Psychiatry 2005, 76:750-751.
19. Bhutta Z.A., Bird S.M., Black R.E., et al. Therapeutic effects of oral zinc in acute and persistent diarrhea in children in developing countries: pooled analysis of randomized controlled trials. Am J Clin Nutr 2000, 72:1516-1522.
20. Patro B., Golicki D., Szajewska H. Meta-analysis: zinc supplementation for acute gastroenteritis in children. Aliment Pharmacol Ther 2008, 28:713-723.
21. Gehrig K.A., Dinulos G.H. Acrodermatitis due to nutritional deficiency. Curr Opin Pediatr 2010, 22:107-112.
22. Wiggelinkhuizen M., Tilanus M.E.C., Bollen C.W., et al. Systematic review: clinical efficacy of chelator agents and zinc in the initial treatment of Wilson disease. Aliment Pharmacol Ther 2009, 29:947-958.
23. Green J.A., Lewin S.R., Wightman F., et al. A randomised controlled trial of oral zinc on the immune response to tuberculosis in HIV-infected patients. Int J Tuberc Lung Dis 2005, 9:1378-1384.
24. Mocchegiani E., Veccia S., Ancarani F., et al. Benefit of oral zinc supplementation as an adjunct to zidovidune (AZT) therapy against opportunistic infections in AIDS. Int J Immunopharmacol 1995, 17:719-727.
25. Stur M., Tittl M., Reitner A., et al. Oral zinc and the second eye in age-related macular degeneration. Invest Ophthalmol Vis Sci 1996, 37:1225-1235.
26. Simkin P.A. Oral zinc sulphate in rheumatoid arthritis. Lancet 1976, ii:539-542.
27. Rasker J.J., Kardaun S.H. Lack of beneficial effect of zinc sulphate in rheumatoid arthritis. Scand J Rheumatol 1982, 11:168-170.
28. Mattingly P.C., Mowat A.G. Zinc sulphate in rheumatoid arthritis. Ann Rhem Dis 1982, 41:456-457.
29. Ewing C.J., Gibbs A.C., Ashcroft C., et al. Failure of oral zinc supplementation in atopic eczema. Eur J Clin Nutr 1991, 45:507-510.
30. Hallbrook T., Lanner E. Serum zinc and healing of venous leg ulcers. Lancet 1972, ii:780-782.
31. Husain L.S. Oral zinc sulphate in leg ulcers. Lancet 1969, i:1069-1070.
32. Broadribb A.J.M., Ricketts C.R. The effect of zinc in the healing of burns. Br J Acc Surg 1971, 3:25-29.
33. Burton J.L., Goolamali S.K. Zinc and sebum excretion. Lancet 1973, i:1448-1450.
34. Weissman K., Wadskov S., Sondergaard J. Oral zinc sulphate therapy for acne vulgaris. Acta Derm Venereol 1977, 57:357-360.
35. Verma K.C., Saini A.S., Dhamija S.K. Oral zinc sulphate therapy in acne vulgaris: a double-blind trial. Acta Derm Venerol 1980, 60:337-340.
36. Hillstrom L., Pettersson L., Hellbe L., et al. Comparison of oral treatment with zinc sulphate and plecbo in acne vulgaris. Br J Dermatol 1977, 97:681-684.
37. Liebovici V., Statteer M., Weinrauch L., et al. Effect of zinc therapy on neutrophil chemotaxis is psoriasis. Isr J Med Sci 1990, 26:306-309.
38. Al-Gurairi F.T., Al-Waix M., Sharque K.E. Oral zinc sulphate in the treatment of recalcitrant viral warts: a randomized placebo-controlled clinical trial. Br J Dermatol 2002, 146:909-913.
39. Merchant H.W., Gangarosa L.P., Glassman A.B., et al. Zinc sulphate supplementation for treatment of recurring oral ulcers. South Med J 1977, 70:559-561.
40. Wray D. A double-blind trial of systemic zinc sulphate in recurrent aphthous stomatitis. Oral Surg Oral Med Oral Pathol 1982, 53:469-472.
41. Orbak R., Cicek Y., Tezel A., et al. Effects of zinc treatment in patients with recurrent aphthous stomatitis. Dent Mater J 2003, 22:21-29.
42. Niewoehner C.B., Allen J.I., Boosalis M., et al. Role of zinc supplementation in type II diabetes mellitus. Am J Med 1986, 81:63-68.
43. Gupta R., Garg V.K., Mathur D.K., et al. Oral zinc therapy in diabetic neuropathy. J Assoc Physicians India 1998, 46:939-942.
44. Prasad A.S., Beck F.W., Kaplan J., et al. Effect of zinc supplementation on incidence of infections and hospitals and hospital infections in sickle cell disease (SCD). Am J Hematol 1999, 61:194-202.
45. Mahajan P.M., Jadhav V.H., Patki A.H., et al. Oral zinc therapy in recurrent erythema nodosum leprosum: a clinical study. Indian J Lepr 1994, 66:51-57.
46. Mathur N.K., Bumb R.A., Mangal H.N. Oral zinc in recurrent erythema nodosum leprosum reaction. Lepr India 1983, 55:547-552.
47. Weisman K., Christensen E., Dreyer V. Zinc supplementation in alcoholic cirrhosis. Acta Med Scand 1979, 205:361-366.
48. Doherty C.P., Sarkar M.A.K., Shakur M.S., et al. Zinc and rehabilitation from severe protein-energy malnutrition: higher dose regimens are associated with increased mortality. Am J Clin Nutr 1998, 68:742-748.
49. Chandra R.K. Excessive intake of zinc impairs immune responses. J Am Med Assoc 1984, 252:1443-1446.
50. Karlsen T.H., Sommerfelt H., Klomstad S., et al. Intestinal and systemic immune response to an oral cholera toxoid B subunit whole-cell vaccine administered during zinc supplementation. Infect Immun 2003, 71:3909-3913.
51. Provinciali M., Montenovo A., Di Stafano G., et al. Effect of zinc or zinc plus arginine supplementation on antibody titre and lymphocyte subsets after influenza vaccination in elderly subjects: a randomised controlled trial. Age Aging 1998, 27:715-722.
52. Duchateau J., Delepesse G., Vrijens R., et al. Beneficial effects of oral zinc supplementation in the lymphocyte response to mitogens of normal subjects. Am J Clin Nutr 1981, 70:1001-1004.
53. Heyland D.K., Jones N., Cvijanovich N.Z., et al. Zinc supplementation in critically ill patients: a key pharmaconeutrient. J Ent Parent Nutr 2008, 32:509-519.